Analytical Data
-
基因名
BGLF2
- Application
-
别名
BGLF2；Non-receptor tyrosine-Protein kinase TYK2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P0CK53
-
表达区间
1-336aa
-
氨基酸序列
MASAANSSREQLRKFLNKECLWVLSDASTPQMKVYTATTAVSAVYVPQIAGPPKTYMNVTLIVLKPKKKPTYVTVYINGTLATVARPEVLFTKAVQGPHSLTLMYFGVFSDAVGEAVPVEIRGNPVVTCTDLTTAHVFTTSTAVKTVEELQDITPSEIIPLGRGGAWYAEGALYMFFVNMDMLMCCPNMPTFPSLTHFINLLTRCDNGECVTCYGAGAHVNILRGWTEDDSPGTSGTCPCLLPCTALNNDYVPITGHRALLGLMFKPEDAPFVVGLRFNPPKMHPDMSRVLQGVLANGKEVPCTAQPWTLLRFSDLYSRAMLYNCQVLKRQVLHSY
-
分子量
44.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BGLF2 is a protein encoded by the Epstein-Barr virus (EBV), a member of the herpesvirus family, which is linked to various human diseases, including infectious mononucleosis and certain cancers. The BGLF2 protein is particularly interesting due to its role in viral replication and its function as a glycoprotein involved in viral assembly and release. Research into BGLF2 focuses on its structural properties, interactions with other viral and host proteins, and its potential as a target for antiviral therapies. Understanding BGLF2's mechanisms could reveal insights into EBV pathogenesis and provide strategies to mitigate EBV-related diseases. With its dual role in both viral life cycle and immune evasion, BGLF2 serves as a crucial component for investigating new therapeutic approaches, including vaccines and antiviral drugs. The ongoing study of BGLF2 contributes significantly to the broader field of virology, particularly in the context of understanding how herpesviruses persist in the host and evade immune responses, thereby underscoring its relevance in medical research and potential clinical applications.
